Financhill
Buy
63

RZLT Quote, Financials, Valuation and Earnings

Last price:
$9.69
Seasonality move :
149.71%
Day range:
$9.28 - $9.85
52-week range:
$2.22 - $11.46
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
5.97x
Volume:
1.6M
Avg. volume:
1.5M
1-year change:
77.01%
Market cap:
$878.1M
Revenue:
--
EPS (TTM):
-$0.93

Analysts' Opinion

  • Consensus Rating
    Rezolute, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 8 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $15.78, Rezolute, Inc. has an estimated upside of 66.61% from its current price of $9.47.
  • Price Target Downside
    According to analysts, the lowest downside price target is $12.00 representing -26.72% downside risk from its current price of $9.47.

Fair Value

  • According to the consensus of 8 analysts, Rezolute, Inc. has 66.61% upside to fair value with a price target of $15.78 per share.

RZLT vs. S&P 500

  • Over the past 5 trading days, Rezolute, Inc. has underperformed the S&P 500 by -0.64% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Rezolute, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Rezolute, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Rezolute, Inc. reported revenues of --.

Earnings Growth

  • Rezolute, Inc. has grown year-over-year earnings for 5 quarters straight. In the most recent quarter Rezolute, Inc. reported earnings per share of -$0.18.
Enterprise value:
727.4M
EV / Invested capital:
4.89x
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
-7.65x
EV / Free cash flow:
-10.32x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$31K
Return On Assets:
-58.09%
Net Income Margin (TTM):
--
Return On Equity:
-63.8%
Return On Invested Capital:
-62.88%
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue -- -- -- -- --
Gross Profit -$366K -$34K -$31K -$8K -$8K
Operating Income -$61.7M -$71.5M -$82.8M -$16.9M -$19.8M
EBITDA -$61.3M -$71.4M -$82.7M -$16.9M -$19.8M
Diluted EPS -$1.10 -$1.27 -$0.93 -$0.22 -$0.18
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $38.3M $155.6M $102.6M $110.2M $154.7M
Total Assets $38.8M $156M $113M $123.4M $158.7M
Current Liabilities $2.6M $2.4M $7.2M $8M $10.2M
Total Liabilities $17.2M $2.9M $9.4M $10M $11.5M
Total Equity $21.6M $153.1M $103.6M $113.4M $147.2M
Total Debt $14.4M $49K $1.8M $1.5M $804K
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations -$47.5M -$62.8M -$70.5M -$16M -$17.4M
Cash From Investing -$98.8M -$3.3M -$33.6M -$49.4M -$68.5M
Cash From Financing -- $68.5M $102.7M $5.5M $911K
Free Cash Flow -$47.6M -$62.8M -$70.5M -$16M -$17.4M
RZLT
Sector
Market Cap
$878.1M
$28.4M
Price % of 52-Week High
82.66%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
-11.99%
-1.32%
1-Year Price Total Return
77.01%
-22.19%
Beta (5-Year)
0.211
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $9.49
200-day SMA
Buy
Level $5.92
Bollinger Bands (100)
Buy
Level 0 - 0
Chaikin Money Flow
Sell
Level --
20-day SMA
Sell
Level $9.78
Relative Strength Index (RSI14)
Buy
Level 52.39
ADX Line
Neutral
Level 0
Williams %R
Neutral
Level -65
50-day SMA
Buy
Level $9.34
MACD (12, 26)
Buy
Level 0.02
25-day Aroon Oscillator
Buy
Level 12
On Balance Volume
Neutral
Level --

Financial Scores

Buy
Altman Z-Score (Annual)
Level (13.786)
Sell
CA Score (Annual)
Level (-0.8811)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (8.8058)
--
Piotroski F Score (Annual)
Level (--)
Sell
Quality Ratio Score
Level (2)
Sell
Fundamental Score
Level (2)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. The firm's antibody therapy, ersodetug, is designed to treat all forms of hyperinsulinism. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada in March 2010 and is headquartered in Redwood City, CA.

Stock Forecast FAQ

In the current month, RZLT has received 8 Buy ratings 0 Hold ratings, and 0 Sell ratings. The RZLT average analyst price target in the past 3 months is $15.78.

  • Where Will Rezolute, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Rezolute, Inc. share price will rise to $15.78 per share over the next 12 months.

  • What Do Analysts Say About Rezolute, Inc.?

    Analysts are divided on their view about Rezolute, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Rezolute, Inc. is a Sell and believe this share price will drop from its current level to $12.00.

  • What Is Rezolute, Inc.'s Price Target?

    The price target for Rezolute, Inc. over the next 1-year time period is forecast to be $15.78 according to 8 Wall Street analysts, 8 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is RZLT A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Rezolute, Inc. is a Buy. 8 of 8 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of RZLT?

    You can purchase shares of Rezolute, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Rezolute, Inc. shares.

  • What Is The Rezolute, Inc. Share Price Today?

    Rezolute, Inc. was last trading at $9.69 per share. This represents the most recent stock quote for Rezolute, Inc.. Yesterday, Rezolute, Inc. closed at $9.47 per share.

  • How To Buy Rezolute, Inc. Stock Online?

    In order to purchase Rezolute, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 61x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 38x

Buy
69
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Sell
47
PSTG alert for Dec 4

Pure Storage, Inc. [PSTG] is up 5.05% over the past day.

Sell
41
SMX alert for Dec 4

SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.

Sell
43
HY alert for Dec 4

Hyster-Yale, Inc. [HY] is up 1.92% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock